Easton Pharmaceuticals to Attend and Introduce Its New & Existing Product Line at the Total Health Show
20 Febbraio 2014 - 2:37PM
Marketwired
Easton Pharmaceuticals to Attend and Introduce Its New &
Existing Product Line at the Total Health Show
TORONTO, ON--(Marketwired - Feb 20, 2014) - Easton
Pharmaceuticals Inc. (OTC: EAPH) a specialty pharmaceutical company
that owns, designs, develops, and markets an array of
topically-delivered drugs and therapeutic / cosmetic healthcare
products, today announces it will attend and present at the Total
Health Show to be held on April 4,5 and 6 in Toronto, Canada.
Easton Pharmaceuticals will be attending and introducing its
over the counter product line at the Total Health Show in April of
2014. The total Health show held in Toronto on April 4, 5, and 6 is
the biggest health show in Canada and one of the biggest in North
America for displaying non drug related, natural, therapeutic
health products, considered one of the biggest in North America
with many well known quest speakers. The show will allow Easton to
introduce its natural therapeutic products which includes a new
wound healing product along with other select products including
"VIORRA," an over-the-counter aid for the treatment to restore and
improve vaginal moisture and elasticity which is believed to have a
positive effect on women's sexual desire and arousal FSAD (Female
Sexual Arousal Disorder), VIORRA is a topical, daily-use product
formulated with ingredients classified by the FDA as (GRAS)
Generally Recognized as Safe.
In addition to attending the Total health Show, Easton
Pharmaceuticals is attempting to book its presence at the expowest
and expoeast health shows, North America's biggest health and trade
shows to display all types of therapeutic health products.
In other developments, Easton pharmaceuticals and its
negotiations on its medical marijuana initiatives with a private
B.C. company are progressing well with what are believed to be some
minor details prior to reaching a final agreement. The B.C. company
has been approved and granted a national growers / distributors
license in the country of Canada for medical marijuana. The company
anticipates closing on an agreement acceptable to both parties in
the coming days, followed by additional news and comprehensive
details.
For More Information Visit http://www.ashleybiomedical.com &
http://www.eastonpharma.com
For More Information On The Total Health Show Visit
http://www.totalhealthshow.com/
Safe Harbor
This news release may contain forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of 1995
(The "Act"). In particular, when used in the preceding of
discussion, the words "anticipate," "pleased," "plan," "confident
that," "believe," "expect," "possible" or "intent to" and similar
conditional expressions are intended to identify forward-looking
statements within the meaning of the Act and are subject to the
safe harbor created by the Act. Such statements are subject to
certain risks and uncertainties and actual results could differ
materially from those expressed in any of the forward-looking
statements. Such risks and uncertainties include, but are not
limited to, market conditions, general acceptance of the company's
products and technologies, competitive factors, the ability to
successfully complete additional or adequate financing, government
approvals or changes to proposed laws and other risks and
uncertainties further stated in the company's financial reports and
filings.
Contact: Carla Pepe Easton Pharmaceuticals Inc. Tel: +1(416)
619-0291 Tel: +1(347) 284-0192 email: info@ashleybiomedical.com
info@lamindustries.com
Grafico Azioni Easton Pharmaceuticals (CE) (USOTC:EAPH)
Storico
Da Mar 2025 a Mar 2025
Grafico Azioni Easton Pharmaceuticals (CE) (USOTC:EAPH)
Storico
Da Mar 2024 a Mar 2025
